Voyager Therapeutics, Inc. Quarterly Depreciation in USD from Q3 2014 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Voyager Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q3 2014 to Q1 2025.
  • Voyager Therapeutics, Inc. Depreciation for the quarter ending March 31, 2025 was $1.01M, a 15.2% decline year-over-year.
  • Voyager Therapeutics, Inc. annual Depreciation for 2024 was $4.73M, a 6.53% increase from 2023.
  • Voyager Therapeutics, Inc. annual Depreciation for 2023 was $4.44M, a 28.3% decline from 2022.
  • Voyager Therapeutics, Inc. annual Depreciation for 2022 was $6.19M, a 19.9% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $1.01M -$182K -15.2% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q1 2024 $1.2M +$121K +11.3% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q1 2023 $1.08M -$1.74M -61.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $2.81M +$1.54M +121% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $1.27M +$432K +51.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 $842K +$226K +36.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $616K +$160K +35.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 $456K +$139K +43.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q1 2017 $317K +$181K +133% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 $136K +$5K +3.82% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q3 2015 $63K -$97K -60.6% Jul 1, 2015 Sep 30, 2015 10-Q 2015-12-17
Q1 2015 $131K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q3 2014 $160K Jul 1, 2014 Sep 30, 2014 10-Q 2015-12-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.